Plain-English translation of NCT06608017 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Read our Allergic Rhinitis research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Hong Kong
Phase
Large-scale testing
Sponsor
Chinese University of Hong Kong
Enrollment target
~140 participants
Started
March 2025
Primary completion
December 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Zhixiu LIN, PhD
Chinese University of Hong Kong
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.